Selected research
Industry Research
Whole Blood, Plasma and Serum Viscometers Industry Research Report 2026
Market perspective
The global Whole Blood, Plasma and Serum Viscometers market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Whole Blood, Plasma and Serum Viscometers is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Whole Blood, Plasma and Serum Viscometers is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Whole Blood, Plasma and Serum Viscometers is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Whole Blood, Plasma and Serum Viscometers include BioFluid Technology, AMETEK Brookfield, Anton Paar, Benson Viscometers, Health Onvector, LAMY RHEOLOGY, LAUDA, RheoSense and Thermo Fisher Scientific, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Whole Blood, Plasma and Serum Viscometers market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Whole Blood, Plasma and Serum Viscometers Market by Company
BioFluid Technology
AMETEK Brookfield
Anton Paar
Benson Viscometers
Health Onvector
LAMY RHEOLOGY
LAUDA
RheoSense
Thermo Fisher Scientific
Whole Blood, Plasma and Serum Viscometers Segment by Type
Rotational Viscometer
Capillary Viscometer
Whole Blood, Plasma and Serum Viscometers Segment by Application
Clinic
Hospital
Laboratory
Whole Blood, Plasma and Serum Viscometers Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Whole Blood, Plasma and Serum Viscometers market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Whole Blood, Plasma and Serum Viscometers and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Whole Blood, Plasma and Serum Viscometers.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Whole Blood, Plasma and Serum Viscometers manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Whole Blood, Plasma and Serum Viscometers by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Whole Blood, Plasma and Serum Viscometers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Rotational Viscometer
- Capillary Viscometer
Applications
- Clinic
- Hospital
- Laboratory
Companies covered
- BioFluid Technology
- AMETEK Brookfield
- Anton Paar
- Benson Viscometers
- Health Onvector
- LAMY RHEOLOGY
- LAUDA
- RheoSense
- Thermo Fisher Scientific
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Whole Blood, Plasma and Serum Viscometers Market Size (2021-2032)
- 2.2.2 Global Whole Blood, Plasma and Serum Viscometers Sales (2021-2032)
- 2.2.3 Global Whole Blood, Plasma and Serum Viscometers Market Average Price (2021-2032)
- 2.3 Whole Blood, Plasma and Serum Viscometers by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Rotational Viscometer
- 2.3.3 Capillary Viscometer
- 2.4 Whole Blood, Plasma and Serum Viscometers by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Clinic
- 2.4.3 Hospital
- 2.4.4 Laboratory
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Whole Blood, Plasma and Serum Viscometers Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Whole Blood, Plasma and Serum Viscometers Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Whole Blood, Plasma and Serum Viscometers Revenue of Manufacturers (2021-2026)
- 3.4 Global Whole Blood, Plasma and Serum Viscometers Average Price by Manufacturers (2021-2026)
- 3.5 Global Whole Blood, Plasma and Serum Viscometers Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Whole Blood, Plasma and Serum Viscometers, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Whole Blood, Plasma and Serum Viscometers, Product Type & Application
- 3.8 Global Manufacturers of Whole Blood, Plasma and Serum Viscometers, Established Date
- 3.9 Global Whole Blood, Plasma and Serum Viscometers Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 BioFluid Technology
- 4.1.1 BioFluid Technology Company Information
- 4.1.2 BioFluid Technology Business Overview
- 4.1.3 BioFluid Technology Whole Blood, Plasma and Serum Viscometers Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 BioFluid Technology Whole Blood, Plasma and Serum Viscometers Product Portfolio
- 4.1.5 BioFluid Technology Recent Developments
- 4.2 AMETEK Brookfield
- 4.2.1 AMETEK Brookfield Company Information
- 4.2.2 AMETEK Brookfield Business Overview
- 4.2.3 AMETEK Brookfield Whole Blood, Plasma and Serum Viscometers Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 AMETEK Brookfield Whole Blood, Plasma and Serum Viscometers Product Portfolio
- 4.2.5 AMETEK Brookfield Recent Developments
- 4.3 Anton Paar
- 4.3.1 Anton Paar Company Information
- 4.3.2 Anton Paar Business Overview
- 4.3.3 Anton Paar Whole Blood, Plasma and Serum Viscometers Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Anton Paar Whole Blood, Plasma and Serum Viscometers Product Portfolio
- 4.3.5 Anton Paar Recent Developments
- 4.4 Benson Viscometers
- 4.4.1 Benson Viscometers Company Information
- 4.4.2 Benson Viscometers Business Overview
- 4.4.3 Benson Viscometers Whole Blood, Plasma and Serum Viscometers Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Benson Viscometers Whole Blood, Plasma and Serum Viscometers Product Portfolio
- 4.4.5 Benson Viscometers Recent Developments
- 4.5 Health Onvector
- 4.5.1 Health Onvector Company Information
- 4.5.2 Health Onvector Business Overview
- 4.5.3 Health Onvector Whole Blood, Plasma and Serum Viscometers Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Health Onvector Whole Blood, Plasma and Serum Viscometers Product Portfolio
- 4.5.5 Health Onvector Recent Developments
- 4.6 LAMY RHEOLOGY
- 4.6.1 LAMY RHEOLOGY Company Information
- 4.6.2 LAMY RHEOLOGY Business Overview
- 4.6.3 LAMY RHEOLOGY Whole Blood, Plasma and Serum Viscometers Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 LAMY RHEOLOGY Whole Blood, Plasma and Serum Viscometers Product Portfolio
- 4.6.5 LAMY RHEOLOGY Recent Developments
- 4.7 LAUDA
- 4.7.1 LAUDA Company Information
- 4.7.2 LAUDA Business Overview
- 4.7.3 LAUDA Whole Blood, Plasma and Serum Viscometers Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 LAUDA Whole Blood, Plasma and Serum Viscometers Product Portfolio
- 4.7.5 LAUDA Recent Developments
- 4.8 RheoSense
- 4.8.1 RheoSense Company Information
- 4.8.2 RheoSense Business Overview
- 4.8.3 RheoSense Whole Blood, Plasma and Serum Viscometers Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 RheoSense Whole Blood, Plasma and Serum Viscometers Product Portfolio
- 4.8.5 RheoSense Recent Developments
- 4.9 Thermo Fisher Scientific
- 4.9.1 Thermo Fisher Scientific Company Information
- 4.9.2 Thermo Fisher Scientific Business Overview
- 4.9.3 Thermo Fisher Scientific Whole Blood, Plasma and Serum Viscometers Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Thermo Fisher Scientific Whole Blood, Plasma and Serum Viscometers Product Portfolio
- 4.9.5 Thermo Fisher Scientific Recent Developments
5 Global Whole Blood, Plasma and Serum Viscometers Market Scenario by Region
- 5.1 Global Whole Blood, Plasma and Serum Viscometers Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Whole Blood, Plasma and Serum Viscometers Sales by Region: 2021-2032
- 5.2.1 Global Whole Blood, Plasma and Serum Viscometers Sales by Region: 2021-2026
- 5.2.2 Global Whole Blood, Plasma and Serum Viscometers Sales by Region: 2027-2032
- 5.3 Global Whole Blood, Plasma and Serum Viscometers Revenue by Region: 2021-2032
- 5.3.1 Global Whole Blood, Plasma and Serum Viscometers Revenue by Region: 2021-2026
- 5.3.2 Global Whole Blood, Plasma and Serum Viscometers Revenue by Region: 2027-2032
- 5.4 North America Whole Blood, Plasma and Serum Viscometers Market Facts & Figures by Country
- 5.4.1 North America Whole Blood, Plasma and Serum Viscometers Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Whole Blood, Plasma and Serum Viscometers Sales by Country (2021-2032)
- 5.4.3 North America Whole Blood, Plasma and Serum Viscometers Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Whole Blood, Plasma and Serum Viscometers Market Facts & Figures by Country
- 5.5.1 Europe Whole Blood, Plasma and Serum Viscometers Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Whole Blood, Plasma and Serum Viscometers Sales by Country (2021-2032)
- 5.5.3 Europe Whole Blood, Plasma and Serum Viscometers Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Whole Blood, Plasma and Serum Viscometers Market Facts & Figures by Country
- 5.6.1 Asia Pacific Whole Blood, Plasma and Serum Viscometers Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Whole Blood, Plasma and Serum Viscometers Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Whole Blood, Plasma and Serum Viscometers Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Whole Blood, Plasma and Serum Viscometers Market Facts & Figures by Country
- 5.7.1 South America Whole Blood, Plasma and Serum Viscometers Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Whole Blood, Plasma and Serum Viscometers Sales by Country (2021-2032)
- 5.7.3 South America Whole Blood, Plasma and Serum Viscometers Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Whole Blood, Plasma and Serum Viscometers Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Whole Blood, Plasma and Serum Viscometers Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Whole Blood, Plasma and Serum Viscometers Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Whole Blood, Plasma and Serum Viscometers Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Whole Blood, Plasma and Serum Viscometers Sales by Type (2021-2032)
- 6.1.1 Global Whole Blood, Plasma and Serum Viscometers Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Whole Blood, Plasma and Serum Viscometers Sales Market Share by Type (2021-2032)
- 6.2 Global Whole Blood, Plasma and Serum Viscometers Revenue by Type (2021-2032)
- 6.2.1 Global Whole Blood, Plasma and Serum Viscometers Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Whole Blood, Plasma and Serum Viscometers Revenue Market Share by Type (2021-2032)
- 6.3 Global Whole Blood, Plasma and Serum Viscometers Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Whole Blood, Plasma and Serum Viscometers Sales by Application (2021-2032)
- 7.1.1 Global Whole Blood, Plasma and Serum Viscometers Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Whole Blood, Plasma and Serum Viscometers Sales Market Share by Application (2021-2032)
- 7.2 Global Whole Blood, Plasma and Serum Viscometers Revenue by Application (2021-2032)
- 7.2.1 Global Whole Blood, Plasma and Serum Viscometers Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Whole Blood, Plasma and Serum Viscometers Revenue Market Share by Application (2021-2032)
- 7.3 Global Whole Blood, Plasma and Serum Viscometers Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Whole Blood, Plasma and Serum Viscometers Value Chain Analysis
- 8.1.1 Whole Blood, Plasma and Serum Viscometers Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Whole Blood, Plasma and Serum Viscometers Production Mode & Process
- 8.2 Whole Blood, Plasma and Serum Viscometers Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Whole Blood, Plasma and Serum Viscometers Distributors
- 8.2.3 Whole Blood, Plasma and Serum Viscometers Customers
9 Global Whole Blood, Plasma and Serum Viscometers Analyzing Market Dynamics
- 9.1 Whole Blood, Plasma and Serum Viscometers Industry Trends
- 9.2 Whole Blood, Plasma and Serum Viscometers Industry Drivers
- 9.3 Whole Blood, Plasma and Serum Viscometers Industry Opportunities and Challenges
- 9.4 Whole Blood, Plasma and Serum Viscometers Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst